Recently fed, lots of free energy
sources. Precursors anabolised
(glucose to glycogen, fatty acids
to triglycerides) for energy stores
High levels of insulin allows
the cells to use glucose from
the blood as an energy
source, promoting the storage
of glucose as glycogen
Post-absorptive
state
Between meals, reduced
free energy sources.
Storage molecules
catabolised into precursors
for energy sources for cells
Insulin levels have fallen,
signalling the catabolism of
stored energy sources.
Insulin is important in
this process and it is
released in three phases
Cephalic
Anticipation, smell and taste of
food activates the neural pathway to
the β cells of the pancreas. Insulin
then signals the decrease in
catabolism of stored energy
sources, preparing the body for food
Gastro-intestinal
When food enters the GI
tract, hormones are released,
releasing more insulin
Substrate
Absorbed nutrients
induce more insulin
release, so levels remain
high after feeding
Plasma Osmolality
An increase in the plasma
concentrate of electrolytes
such as Na+ and Cl-
inhibits feeding, as well as
increasing thirst
Feeding is reduced when water is
withheld (dehydration anorexia) or is
accompanied with a hypertonic fluid.
Effect is mediated by
osmoreceptors in the
brainstem
Satiety Signals
Physical and chemical
signals affecting the
regulation of short and long
term feeding behaviour
Gastric distension
Activation of stretch
receptors after
feeding as stomach
volume increases
Signals the
sensation of
feeling full
Decreases feeding,
although this reflex
can be overidden
Cholecystokinin (CKK)
Secreted into
the stomach to
aid digestion
and absorption
Binds to receptors on
the vagus nerve,
aiding the inhibitory
effects of gastric
distension on appetite
Can be blocked by receptor
antagonists and lesions to
the nucleus of solitary tract
(NTS), which is where the
impulses are received
Adiposity
Body fat levels affect
feeding behaviour
Food deprivation with weight
loss leads to increased
feeding until the level of
adiposity is restored
Forced feeding with weight
gain leads to decreased
feeding until adiposity has
returned to normal levels
Parabionts
Two animals surgically
joined by skin or muscle with
the same circulation but
individual nervous systems
Joining a lean and obese animal
causes the lean animal to lose
weight, suggesting that factors
released by the obese animal cause
a decreased food intake and
increased satiety in the lean animal
Proof that fat deposits communicate
with the brain by releasing chemical
mediators into the circulation
Leptin
Hormone
secreted into
the blood by
adipose tissue
Levels in the plasma
are directly proportional
to adiposity
Negative feedback for
caloric homeostasis
Mutations
Receptor
Hyperphagia
and obesity
Leptin administration
does not cure as the
receptor is inactivated
Ob-R, cytokine receptor
found in hypothalamus. Carry
out intracellular signalling via
the Jak/Stat pathway
Gene
Hyperphagia
and obesity
Leptin
administration
cures
Mutations in the insulin
receptor gene increases
feeding and causes obesity
Human obesity is
linked to leptin and
insulin resistances
Dual Centre Hypothesis
Ventromedial Nuclei (VMN)
Satiety centre
Lesions induce
hyperphagia
and obesity
Also causes autonomic
dysfunction, increased
insulin resistance and
eating more often
New feeding set point is established
and eating stops when the new
increased weight is reached
Lateral Hypothalamus (LH)
Hunger centre
Lesions
induce aphagia
and starvation
Also causes
adipsia,
akinesia and
sensory neglect
Neuropeptides
Lateral Nucleus (LH)
Appetite stimulation
AgRP
Released from arcuate
nucleus, enhances appetite
by acting as an MC4
receptor antagonist, blocking
the effects of α-MSH
Prevents a decrease in orexin A
release from the LH, as well as
preventing the increase of CRH
release in the PVN.
Long lasting effects
NPY
Released from the arcuate
nucleus and enhances appetite by
acting on NPY receptors (Y1 and
Y5) in the PVN and LH.
Increases
orexin A release
and inhibits CRH
Strong, but short lived effects
Paraventricular
Nucleus (PVN)
Appetite suppression
α-MSH
Released from the
arcuate nucleus and
suppresses appetite
by inhibiting orexin A
(which increases
feeding) release from
the LH, and
increasing CRH
(which decreases
feeding) from the
PVN
Binds to
melanocortin
receptors
(MC4) in the
PVN and LH
Receptors important as
mutations in these, as
well as receptor
antagonists may cause
hyperphagia and obesity
MC4 agonists are potential
therapeutic agents for obesity
Arcuate nucleus regulates
indirectly, via the PVN and
LH. Its neuropeptides are
released into the nuclei,
affecting the release of other
neuropeptides. Opposite
effects on the PVN and LH
When bound to its receptor in
the arcuate nucleus, leptin has
the opposite effects on appetite
suppressing and enhancing
neuropeptides. It therefore
decreases feeding by directly
and indirectly affecting the
release of various neuropeptides
in many hypothalamic nuclei
Two main views on how
appetite is regulated
Depletion - Repletion Model
Feeding due to
decreased levels of
energy sources (storage?)
Caloric Homeostasis Model
Feeding due to decreased 'satiety
signals' produced from the last meal.
This would serve to maintain constant
levels of free and stored energy sources